General Information
Project name: Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection
- Acronym:HIVACAR
- Grant Agreement Number:731626 — HIVACAR — H2020-SC1-2016-2017/H2020-SC1-2016-RTD
- Project coordinator:Dr. Felipe Garcia, IDIBAPS (Institut d’Investigacions Biomèdiques August Pi i Sunyer)
- Duration:60 months
- Project start date:01.01.17
- Project end date:31.12.2021
- Number of partners:14
- Project cost:
- Funding:6.685,111.00 €
A community-led psychosocial survey about HIV remission aims to assess the knowledge and expectations among people living with HIV
Are you a person living with #HIV based in Belgium, Denmark, France or Spain? The European AIDS Treatment Group (EATG), HIV community partner within the #HIVACAR initiative, invites you to fill in ๐ ๐จ๐ช๐ง๐ซ๐๐ฎ to help better understand ๐ฎ๐ค๐ช๐ง ๐ ๐ฃ๐ค๐ฌ๐ก๐๐๐๐ ๐๐๐ค๐ช๐ฉ ๐๐๐ ๐ง๐๐ข๐๐จ๐จ๐๐ค๐ฃ...
HIVACAR aims to provide a new therapeutic alternative
Currently, over 36 million people worldwide are infected with HIV, most of them living in developing countries1. In 2014, 1.2 million people died of AIDS-related illnesses…